Similar articles

• Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems.

  McGeer PL, McGeer EG, Hattori T. McGeer PL, et al. Adv Biochem Psychopharmacol. 1977;16:397-402. Adv Biochem Psychopharmacol. 1977. PMID: 329651 No abstract available.
• Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.

  Bartholini G, Scatton B, Worms P, Zivkovic B, Lloyd KG. Bartholini G, et al. Adv Biochem Psychopharmacol. 1981;30:119-28. Adv Biochem Psychopharmacol. 1981. PMID: 6120626 No abstract available.
• Inhibition of dopaminergic activity in the extrapyramidal and limbic systems by gamma-acetylenic GABA [proceedings].

  Huot S, Lippert B, Palfreyman MG, Schechter PJ. Huot S, et al. Br J Pharmacol. 1977 Jun;60(2):264P-265P. Br J Pharmacol. 1977. PMID: 880435 Free PMC article. No abstract available.
• [Recent data on the mode of action of neuroleptics].

  Bartholini G. Bartholini G. Actual Pharmacol (Paris). 1978;30:35-47. Actual Pharmacol (Paris). 1978. PMID: 28640 Review. French. No abstract available.
• The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review.

  Sayed Y, Garrison JM. Sayed Y, et al. Psychopharmacol Bull. 1983 Spring;19(2):283-8. Psychopharmacol Bull. 1983. PMID: 6135238 Review. No abstract available.